Analysis of COVID 19 with HRCT Chest in IGRA negative patients- A study in a COVID Hospital of Odisha
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 50
- 试验地点
- 1
- 主要终点
- The cases were evaluated by a panel of skilled radiologists for identifying the imaging characteristics to develop a generalised protocol to differentiate COVID-19 from TB in Indian population
研究概览
简要总结
The outbreak ofCOVID-19 started in December 2019, in Wuhan, China.China has accumulated huge clinicalexperience and reported about epidemiological, clinical, laboratory, andimaging features. **In India,atthe time of writing there are around 1.4 lakhs confirmed cases of COVID-19 outof which approximately 3800 are dead.**Asfar as Tuberculosis is concerned, World health organisation (WHO)statistics for 2011 giving an estimated incidence figure of 2.2 million casesof TB for India out of a global incidence of 9.6 million cases. In India each year, approximately220,000 deaths are reported due to Tuberculosis. This publichealth problemis the world’s largest Tuberculosis epidemic. Keeping in mind the effectsof Tuberculosis in India and its imaging wise similarities with COVID-19, it isnecessary to develop some imaging protocols which can differentiate TB fromCOVID-19 on HRCT thorax .
This paper attempts to indicate the imaging findingsin COVID patients associated with Tuberculosis and hence to differentiate theboth similarly looking entity on HRCT thus leading to effective managementaccordingly.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 6.00 Year(s) 至 90.00 Year(s)（—）
- 性别
- All
入选标准
- •1.COVID 19 positive patients with imaging features suggestive of exposure to M.
- •Tuberculosis.
- •2.Those COVID positive patients who have undergone both HRCT and IGRA.
排除标准
- •COVID 19 negative patients Absence of any evidence of TB on imaging Those who have not undergone IGRA Those who have refused IV contrast study when indicated.
结局指标
主要结局
The cases were evaluated by a panel of skilled radiologists for identifying the imaging characteristics to develop a generalised protocol to differentiate COVID-19 from TB in Indian population
时间窗: 6 months
次要结局
- To assess the prevalence of TB as co-morbidity with COVID in the study population.(6 months)